TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06210854: Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 48 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$1,617,000

Rescue Site Savings

+$1,058,400

Unlock Full NCT06210854 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06210854 Rescue Dossier →